9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Fluidx Medical Technology, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Cedars-Sinai Medical Center
Stanford University
National Cancer Institute (NCI)
Celgene
InSightec
InSightec
OPKO Health, Inc.
InSightec
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Novartis
Centre Hospitalier Universitaire de Besancon
InSightec
University of South Florida
AstraZeneca
InSightec
The University of Texas Health Science Center at San Antonio
Mannkind Corporation